clinical trial · NCT06441812
A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
Guangdong Hengrui Pharmaceutical Co., Ltd·phase2·recruiting·n = 200
Eosinophilic Asthma PatientsSHR-1703 Injection
brief summary
The purpose of this study is to evaluation the long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
started
Jul 19, 2024
primary completion
Sep 1, 2028
completion
Sep 1, 2028
last updated
Dec 18, 2025
official title
A Multicenter, Single-group Phase II Clinical Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of Multiple Subcutaneous Injections of SHR-1703 in Eosinophilic Asthma Patients
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol